Summary

Sterility Testing Market – Scope of Report
TMR’s report on the global sterility testing market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global sterility testing market for the period 2017–2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global sterility testing market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the sterility testing market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global sterility testing market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global sterility testing market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global sterility testing market.

The report delves into the competitive landscape of the global sterility testing market. Key players operating in the global sterility testing market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global sterility testing market profiled in this report.

Key Questions Answered in Global sterility testing Market Report
• What is the sales/revenue generated by sterility testing across all regions during the forecast period?
• What are the opportunities in the global sterility testing market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2031?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?

Sterility Testing Market – Research Objectives and Research Approach
The comprehensive report on the global sterility testing market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global sterility testing market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global sterility testing market.

ページTOPに戻る

Table of Contents

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Sterility Testing Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Sterility Testing Market Analysis and Forecast, 2017–2031
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product/Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global Sterility Testing Market Analysis and Forecast, by Product
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product, 2017–2031
6.3.1. Kits and Reagents
6.3.2. Instruments
6.3.3. Others
6.4. Market Attractiveness Analysis, by Product
7. Global Sterility Testing Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Application, 2017–2031
7.3.1. Biopharmaceutical Manufacturing
7.3.2. Medical Device Manufacturing
7.3.3. Others
7.4. Market Attractiveness Analysis, by Application
8. Global Sterility Testing Market Analysis and Forecast, by Test Type
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Test Type, 2017–2031
8.3.1. Traditional Sterility Tests
8.3.1.1. Membrane Filtration
8.3.1.2. Immersion Test
8.3.2. Rapid Sterility Tests
8.3.2.1. Solid Phase Cytometry
8.3.2.2. Flow Cytometry
8.3.2.3. Bioluminescence
8.3.2.4. Nucleic Acid Amplification
8.3.2.5. Immunological Methods
8.3.2.6. Others
8.4. Market Attractiveness Analysis, by Application
9. Global Sterility Testing Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region, 2017–2031
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Sterility Testing Market Analysis and Forecast
10.1. Introduction
10.2. Key Findings
10.3. Market Value Forecast, by Product, 2017–2031
10.3.1. Kits and Reagents
10.3.2. Instruments
10.3.3. Others
10.4. Market Value Forecast, by Application, 2017–2031
10.4.1. Biopharmaceutical Manufacturing
10.4.2. Medical Device Manufacturing
10.4.3. Others
10.5. Market Value Forecast, by Test Type, 2017–2031
10.5.1. Traditional Sterility Tests
10.5.1.1. Membrane Filtration
10.5.1.2. Immersion Test
10.5.2. Rapid Sterility Tests
10.5.2.1. Solid Phase Cytometry
10.5.2.2. Flow Cytometry
10.5.2.3. Bioluminescence
10.5.2.4. Nucleic Acid Amplification
10.5.2.5. Immunological Methods
10.5.2.6. Others
10.6. Market Value Forecast, by Country, 2017–2031
10.6.1. U.S.
10.6.2. Canada
10.7. Market Attractiveness Analysis
10.7.1. By Product
10.7.2. By Application
10.7.3. By Test Type
10.7.4. By Country
11. Europe Sterility Testing Market Analysis and Forecast
11.1. Introduction
11.2. Key Findings
11.3. Market Value Forecast, by Product, 2017–2031
11.3.1. Kits and Reagents
11.3.2. Instruments
11.3.3. Others
11.4. Market Value Forecast, by Application, 2017–2031
11.4.1. Biopharmaceutical Manufacturing
11.4.2. Medical Device Manufacturing
11.4.3. Others
11.5. Market Value Forecast, by Test Type, 2017–2031
11.5.1. Traditional Sterility Tests
11.5.1.1. Membrane Filtration
11.5.1.2. Immersion Test
11.5.2. Rapid Sterility Tests
11.5.2.1. Solid Phase Cytometry
11.5.2.2. Flow Cytometry
11.5.2.3. Bioluminescence
11.5.2.4. Nucleic Acid Amplification
11.5.2.5. Immunological Methods
11.5.2.6. Others
11.6. Market Value Forecast, by Country/Sub-region, 2017–2031
11.6.1. Germany
11.6.2. U.K.
11.6.3. France
11.6.4. Italy
11.6.5. Spain
11.6.6. Rest of Europe
11.7. Market Attractiveness Analysis
11.7.1. By Product
11.7.2. By Application
11.7.3. By Test Type
11.7.4. By Country/Sub-region
12. Asia Pacific Sterility Testing Market Analysis and Forecast
12.1. Introduction
12.2. Key Findings
12.3. Market Value Forecast, by Product, 2017–2031
12.3.1. Kits and Reagents
12.3.2. Instruments
12.3.3. Others
12.4. Market Value Forecast, by Application, 2017–2031
12.4.1. Biopharmaceutical Manufacturing
12.4.2. Medical Device Manufacturing
12.4.3. Others
12.5. Market Value Forecast, by Test Type, 2017–2031
12.5.1. Traditional Sterility Tests
12.5.1.1. Membrane Filtration
12.5.1.2. Immersion Test
12.5.2. Rapid Sterility Tests
12.5.2.1. Solid Phase Cytometry
12.5.2.2. Flow Cytometry
12.5.2.3. Bioluminescence
12.5.2.4. Nucleic Acid Amplification
12.5.2.5. Immunological Methods
12.5.2.6. Others
12.6. Market Value Forecast, by Country/Sub-region, 2017–2031
12.6.1. China
12.6.2. Japan
12.6.3. India
12.6.4. Australia & New Zealand
12.6.5. Rest of Asia Pacific
12.7. Market Attractiveness Analysis
12.7.1. By Product
12.7.2. By Application
12.7.3. By Test Type
12.7.4. By Country/Sub-region
13. Latin America Sterility Testing Market Analysis and Forecast
13.1. Introduction
13.2. Key Findings
13.3. Market Value Forecast, by Product, 2017–2031
13.3.1. Kits and Reagents
13.3.2. Instruments
13.3.3. Others
13.4. Market Value Forecast, by Application, 2017–2031
13.4.1. Biopharmaceutical Manufacturing
13.4.2. Medical Device Manufacturing
13.4.3. Others
13.5. Market Value Forecast, by Test Type, 2017–2031
13.5.1. Traditional Sterility Tests
13.5.1.1. Membrane Filtration
13.5.1.2. Immersion Test
13.5.2. Rapid Sterility Tests
13.5.2.1. Solid Phase Cytometry
13.5.2.2. Flow Cytometry
13.5.2.3. Bioluminescence
13.5.2.4. Nucleic Acid Amplification
13.5.2.5. Immunological Methods
13.5.2.6. Others
13.6. Market Value Forecast, by Country/Sub-region, 2017–2031
13.6.1. Brazil
13.6.2. Mexico
13.6.3. Rest of Latin America
13.7. Market Attractiveness Analysis
13.7.1. By Product
13.7.2. By Application
13.7.3. By Test Type
13.7.4. By Country/Sub-region
14. Middle East & Africa Sterility Testing Market Analysis and Forecast
14.1. Introduction
14.2. Key Findings
14.3. Market Value Forecast, by Product, 2017–2031
14.3.1. Kits and Reagents
14.3.2. Instruments
14.3.3. Others
14.4. Market Value Forecast, by Application, 2017–2031
14.4.1. Biopharmaceutical Manufacturing
14.4.2. Medical Device Manufacturing
14.4.3. Others
14.5. Market Value Forecast, by Test Type, 2017–2031
14.5.1. Traditional Sterility Tests
14.5.1.1. Membrane Filtration
14.5.1.2. Immersion Test
14.5.2. Rapid Sterility Tests
14.5.2.1. Solid Phase Cytometry
14.5.2.2. Flow Cytometry
14.5.2.3. Bioluminescence
14.5.2.4. Nucleic Acid Amplification
14.5.2.5. Immunological Methods
14.5.2.6. Others
14.6. Market Value Forecast, by Country/Sub-region, 2017–2031
14.6.1. GCC Countries
14.6.2. South Africa
14.6.3. Rest of Middle East & Africa
14.7. Market Attractiveness Analysis
14.7.1. By Product
14.7.2. By Application
14.7.3. By Test Type
14.7.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
15.2. Market Share Analysis, by Company (2022)
15.3. Company Profiles
15.3.1. bioMerieux SA
15.3.1.1. Company Overview
15.3.1.2. Product Portfolio
15.3.1.3. SWOT Analysis
15.3.1.4. Financial Overview
15.3.1.5. Strategic Overview
15.3.2. Merck KGaA
15.3.2.1. Company Overview
15.3.2.2. Product Portfolio
15.3.2.3. SWOT Analysis
15.3.2.4. Financial Overview
15.3.2.5. Strategic Overview
15.3.3. Thermo Fisher Scientific
15.3.3.1. Company Overview
15.3.3.2. Product Portfolio
15.3.3.3. SWOT Analysis
15.3.3.4. Financial Overview
15.3.3.5. Strategic Overview
15.3.4. Sartorius AG
15.3.4.1. Company Overview
15.3.4.2. Product Portfolio
15.3.4.3. SWOT Analysis
15.3.4.4. Financial Overview
15.3.4.5. Strategic Overview
15.3.5. Charles River Laboratories International, Inc.
15.3.5.1. Company Overview
15.3.5.2. Product Portfolio
15.3.5.3. SWOT Analysis
15.3.5.4. Financial Overview
15.3.5.5. Strategic Overview
15.3.6. Solvias AG
15.3.6.1. Company Overview
15.3.6.2. Product Portfolio
15.3.6.3. SWOT Analysis
15.3.6.4. Financial Overview
15.3.6.5. Strategic Overview
15.3.7. Becton, Dickinson and Company
15.3.7.1. Company Overview
15.3.7.2. Product Portfolio
15.3.7.3. SWOT Analysis
15.3.7.4. Financial Overview
15.3.7.5. Strategic Overview
15.3.8. Rapid Micro Biosystems, Inc.
15.3.8.1. Company Overview
15.3.8.2. Product Portfolio
15.3.8.3. SWOT Analysis
15.3.8.4. Financial Overview
15.3.8.5. Strategic Overview